UnitedHealth Group has appointed Stephen J. Hemsley as its CEO with immediate effect, succeeding Andrew Witty. Witty’s departure from the CEO position was due to “personal reasons”, the company said in a statement. Hemsley, the company’s former CEO, will retain his position as chairman of the Board of Directors, while Witty will transition to a senior advisory role to Hemsley. Hemsley joined as chief operating officer in 1997 before becoming president in 1999. He was the CEO from 2006 to 2017 and took on the responsibility of board chair in 2017. Hemsley said: “We are grateful for Andrew’s stewardship of UnitedHealth Group, especially during some of the most challenging times any company has ever faced. The Board and I have greatly valued his leadership and compassion as chief executive and as a director and wish him and his family the best. Witty stated: “Leading the people of UnitedHealth Group has been a tremendous honour as they work every day to improve the health system, and they will continue to inspire me.” Concurrently, UnitedHealth has announced the suspension of its financial outlook for 2025. The health insurer said this decision comes amid an acceleration in care activity and expansion into a broader range of benefit offerings than previously anticipated in the first quarter (Q1). Furthermore, the medical costs for several Medicare Advantage beneficiaries new to UnitedHealthcare have been higher than expected, the company said. Hemsley added: “UnitedHealth Group has tremendous opportunities to grow as we continue to help improve health care and to perform to our potential – and, in so doing, return to our long-term growth objective of 13 to 16 percent.” UnitedHealth expects to “return to growth” next year. This follows the company swing back to profit in Q1 2025, with net earnings of $6.4bn, as against a net loss of $1.2bn in the same quarter of 2024. "UnitedHealth Group names new CEO " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
UnitedHealth Group names new CEO
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...